Rigel Pharmaceuticals (RIGL) Treasury Shares (2021 - 2026)

Rigel Pharmaceuticals' Treasury Shares history runs 6 years deep, the most recent figure standing at $67200.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 88.17% year-over-year to $67200.0; the TTM figure through Mar 2026 stood at $67200.0 (down 88.17% YoY), while the FY2025 annual figure was $607621.0, up 56.89% from the prior year.
• Treasury Shares was $67200.0 for Q1 2026 at Rigel Pharmaceuticals, down from $607621.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.1 million in Q1 2024 to a low of $67200.0 in Q1 2026.
• Historically, Treasury Shares has averaged $1.1 million across 5 years, with a median of $607621.0 in 2025.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares surged 387.8% in 2022, then plunged 88.17% in 2026.
• A 5-year view of Treasury Shares shows it stood at $1.1 million in 2022, then sank by 83.15% to $185938.0 in 2023, then jumped by 108.29% to $387282.0 in 2024, then soared by 56.89% to $607621.0 in 2025, then slumped by 88.94% to $67200.0 in 2026.
• The last three Treasury Shares figures came in at $67200.0 (Q1 2026), $607621.0 (Q4 2025), and $569106.0 (Q3 2025), per Business Quant data.